A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer

Platinum-based combination chemotherapy was associated with survival benefit, as compared with X monotherapy in elderly patients with GC.